Cardiac

  • Red human heart drawing on blue background
    Image attribution tooltip
    Jolygon via Getty Images
    Image attribution tooltip

    3 takeaways from ACC 2025

    Medtronic, Abbott and Boston Scientific had updates on their devices used in heart valve disease treatment at the event.

    By • April 2, 2025
  • A picture of a medical catheter against a white background.
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott snags early CE mark for Volt PFA device

    With PFA becoming physicians’ preferred ablation method for treating AFib, Abbott is pushing to catch up with rival systems already on the market.

    By • March 28, 2025
  • Front sign of FDA building Explore the Trendline➔
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip
    Trendline

    Medical device safety in spotlight after high profile recalls

    From Philips’ massive recall of respiratory devices to ongoing health risks with breast implants, medical devices tied to patient harm have put a focus on product safety.

    By MedTech Dive staff
  • Abbott company sign outside
    Image attribution tooltip

    Courtesy of Abbott Laboratories

    Image attribution tooltip

    Abbott gets FDA nod to begin IVL trial after rivals buy up competition

    J&J acquired the IVL device maker Shockwave Medical last year for $13.1 billion, and Boston Scientific agreed to buy Bolt Medical in January for up to $664 million.

    By • March 25, 2025
  • A view of Boston Scientific's corporate headquarters in Marlborough, Massachusetts, with a clear blue sky in the background.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific leads $175M investment in 4C Medical

    The money will support an ongoing pivotal trial of 4C Medical Technologies' transcatheter mitral valve replacement device in the U.S. and Europe.

    By • March 6, 2025
  • A headshot of Field Medical CEO Steven Mickelsen.
    Image attribution tooltip
    Permission granted by Field Medical
    Image attribution tooltip
    Q&A

    Steven Mickelsen, Farapulse founder, eyes next frontier in pulsed field ablation

    Mickelsen, whose work led to the development of Boston Scientific’s fast-growing Farapulse device, is building a new PFA tool for ventricular tachycardia as CEO of startup Field Medical.

    By • March 4, 2025
  • A photo of Johnson & Johnson's pulsed field ablation system for atrial fibrillation.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    FDA recall notice details J&J pause of Varipulse

    Four of the 132 patients treated with Varipulse in the first two months of the U.S. launch had a form of stroke shortly after surgery.

    By • March 3, 2025
  • Two doctors look at two computer screens that have medical images of a patient's brain.
    Image attribution tooltip
    Courtesy of Brainomix
    Image attribution tooltip

    Medtronic partners with Brainomix on AI stroke tool

    Medtronic also recently teamed with Tempus to assess the use of artificial intelligence to identify people eligible for interventions like TAVR.

    By • Feb. 28, 2025
  • A white, rounded hourglass-shaped patch says "vitalconnect"
    Image attribution tooltip
    Courtesy of VitalConnect
    Image attribution tooltip

    VitalConnect raises $100M for heart monitor patch

    VitalConnect will use the money to commercialize the monitor, which detects arrhythmias and competes with patches from companies including iRhythm.

    By • Feb. 21, 2025
  • A photo of Johnson & Johnson's pulsed field ablation system for atrial fibrillation.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J resumes PFA cases, but analysts warn safety may hamper rollout

    J.P. Morgan analysts said the findings of J&J’s investigation “could significantly hinder the product’s rollout in the U.S. and globally” and lead doctors to “de-prioritize Varipulse.”

    By • Feb. 18, 2025
  • An image of Edwards Lifesciences' Irvine, California, campus at dusk.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards predicts second-half lift from TAVR label expansion

    Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this year.

    By • Feb. 12, 2025
  • FDA headquarters with sign in foreground
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA posts early alert about BD device linked to 30 injuries, 4 deaths

    The alert was posted one day after BD sent customers a letter warning about the risk of atherectomy catheters breaking.

    By • Feb. 10, 2025
  • Recruitment or leadership concept. People row with spotlight highlighted one - creative visualization of people challenge competition
    Image attribution tooltip
    Getty Images via Getty Images
    Image attribution tooltip

    Pulse Biosciences names new CFO, continuing string of C-suite changes

    Pulse, which named a new CEO last month, is pitching its pulsed field ablation technology as a way to shorten procedure times.

    By • Feb. 5, 2025
  • Photo of Michael F. Mahoney, CEO of Boston Scientific.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific closes its year of PFA on a high note

    Farapulse, Boston Scientific’s pulsed field ablation product, fueled year-over-year growth of nearly 171% in the fourth quarter for the company’s electrophysiology group.

    By • Feb. 5, 2025
  • A picture of the surgeon's console for Intuitive Surgical's da Vinci 5 surgical robot.
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip
    2025 outlook

    Top medtech trends in 2025: New products and M&A are bright spots, but Trump brings uncertainty

    Experts highlighted surgical robotics, artificial intelligence and M&A as top trends this year. However, the Trump administration could create challenges for the industry.

    By • Jan. 31, 2025
  • A picture of Getinge's headquarters building in Gothenburg, Sweden.
    Image attribution tooltip
    Courtesy of Getinge
    Image attribution tooltip

    Getinge exits surgical perfusion, creating opportunity for Livanova

    Getinge CEO Mattias Perjos said surgical perfusion has “been a struggling category” since an FDA consent decree forced the company off the U.S. market in 2015.

    By • Jan. 30, 2025
  • A picture of two people staring at the camera, one is leaning against a wall and one is sitting on a bench, in a white room.
    Image attribution tooltip
    Courtesy of Neko Health
    Image attribution tooltip

    Neko Health raises $260M to expand body scan service, fund R&D

    The company uses various medical devices to noninvasively check moles, the heart and more.

    By • Jan. 28, 2025
  • A picture of a blue pulsed field ablation catheter against a gray background.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    Doctors expect Boston Scientific to lead PFA race, survey finds

    Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s current pause of U.S. cases, according to a poll by BTIG.

    By • Jan. 27, 2025
  • A picture of building with large glass windows and a parking lot, with flowers and grass in the foreground
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip

    Abbott expects to launch first PFA device outside of the US this year

    CEO Robert Ford also plans to expand sales of the company’s Lingo over-the-counter glucose sensors after a limited rollout.

    By • Jan. 22, 2025
  • an interior shot of johnson and Johnson corporate lobby featuring signage
    Image attribution tooltip
    Permission granted by Johnson & Johnson
    Image attribution tooltip

    J&J coordinating with FDA on US pause of Varipulse due to safety risks

    Johnson & Johnson executives, on a Wednesday earnings call, did not provide a timeline for when U.S. Varipulse cases will restart after halting procedures in early January.

    By • Jan. 22, 2025
  • A view of Boston Scientific's corporate headquarters in Marlborough, Massachusetts, with a clear blue sky in the background.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific study meets goals for PFA in persistent AFib

    The results will support the company’s application for expanded labeling of its popular Farapulse pulsed field ablation system in a larger group of patients with atrial fibrillation.

    By • Jan. 21, 2025
  • San Francisco Golden Gate
    Image attribution tooltip
    Jason Doiy / Getty Images via Getty Images
    Image attribution tooltip

    JPM25 recap: Robotics, PFA and OTC glucose sensors in the spotlight

    CEOs from Medtronic, Intuitive Surgical, Boston Scientific and Dexcom were on hand this week in San Francisco to discuss the year ahead at the J.P. Morgan Healthcare Conference.

    By • Jan. 17, 2025
  • Boston Scientific's Farapulse pulsed field ablation device.
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip

    Boston Scientific ups PFA forecast, targets market leadership

    At the J.P. Morgan Healthcare Conference, Boston Scientific forecast that pulsed field ablation will be used in more than 60% of atrial fibrillation procedures globally by 2026.

    By • Jan. 15, 2025
  • Image attribution tooltip
    Patrik Stollarz / Staff via Getty Images
    Image attribution tooltip

    Philips recall of heart monitor software tied to 109 injuries, 2 deaths

    Some electrocardiogram events, such as atrial fibrillation or abnormally rapid heartbeats, over two years were not reviewed by healthcare professionals due to a data routing issue.

    By • Jan. 14, 2025
  • Medtronic's Affera all-in-one ablation system
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    CEO Geoff Martha tells JPM crowd Medtronic is ‘stacking growth drivers’

    New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, Martha said Monday at the J.P. Morgan Healthcare Conference.

    By • Jan. 14, 2025
  • Rendering of a spiral-shaped catheter with four electrodes
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    CMS starts Medicare coverage analysis for Medtronic, Recor renal denervation devices

    J.P. Morgan analysts said the CMS’ review “validates the technology and could potentially move the needle on growth for Medtronic.”

    By • Jan. 14, 2025